Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sedative regimens for drug-induced sleep endoscopy in obstructive sleep apnea
PACTR201706002232945Not yet recruiting
- Sponsor
- Rehab Said ELKalla
- Start
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of propofol, dexmedetomidine and ketofol in obstructive sleep apnea hypopnea syndrome (OSAHS) (3 arms), sponsored by Rehab Said ELKalla. Primary endpoint: Incidence of oxygen desaturation. Planned start May 2017; status: not yet recruiting.
02
Drugs
propofoldexmedetomidineketofol
03
Conditions
obstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on PACTR201706002232945.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201706002232945.